![](/wp-content/uploads/2018/10/Xa3qVapCRsqDezhPmtuf.png)
$599
Libre 2 Available for Medicare Patients; Senseonics Receives Positive Medicare Local Coverage Determinations
Abbott announced its Libre 2 CGM system is now available for Medicare patients. Additionally, Senseonics announced that three Medicare Administrative Contractors (MACs) issued Local Coverage Determinations for the use of implantable CGMs. Below, FENIX provides insight into the Abbott and Senseonics Medicare news, including thoughts on how Abbott is more likely to benefit than Senseonics/Ascensia due to the ongoing COVID-19 pandemic.